
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss Shire's increasingly complicated ambition to acquire Baxalta, the changing climate of biotech venture capital and the future of Valeant Pharmaceuticals.
Shire's byzantine Baxalta pursuit, biotech's pragmatic winter and Valeant's CEO shakeup is an episode from FierceBiotech Radio. Fierce editors discuss Shire's increasingly complicated ambition to acquire Baxalta, the changing climate of bio...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Jan 8, 2016, 22:37 long, audio available.
Fierce editors discuss Shire's increasingly complicated ambition to acquire Baxalta, the changing climate of biotech venture capital and the future of Valeant Pharmaceuticals.
You can listen to Shire's byzantine Baxalta pursuit, biotech's pragmatic winter and Valeant's CEO shakeup online on Radio and Podcast. Open the player on this page to stream the available audio.
Shire's byzantine Baxalta pursuit, biotech's pragmatic winter and Valeant's CEO shakeup is an episode from FierceBiotech Radio.
This episode is 22:37 long.
This episode was published on Jan 8, 2016.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
You can listen to Shire's byzantine Baxalta pursuit, biotech's pragmatic winter and Valeant's CEO shakeup on this page when the episode audio is available from the podcast feed.
Shire's byzantine Baxalta pursuit, biotech's pragmatic winter and Valeant's CEO shakeup is from FierceBiotech Radio.
Published Jan 8, 2016 and 22:37 long